Rundu Pharmaceutical (Wuhan) Research Institute Co., Ltd. (Wuhan Research Institute) is a wholly-owned subsidiary of Zhuhai Rundu Pharmaceutical Co., Ltd. (Rundu Pharma, stock code: 002923).
Founded in 2018 and located in Donghu High-tech Development Zone, Wuhan City, Hubei Province, Wuhan Research Institute is mainly engaged in process development, quality research and registration of chemical drugs (including pharmaceutical intermediates, APIs, and drug products).
With a total construction area of about 5,000 square meters, Wuhan Research Institute has a complete quality management system, advanced process equipment and analytical instruments, a R&D team with GMP management and implementation experience, R&D and project management experience, with the solid technical foundation and strong project operation and management capabilities.